2025 International Fall Summit
October 15, 2025 | 12:00 PM EST
- Home
- Clinical Resources Search
- PQI: Encorafenib (Braftovi®) + Cetuximab (Erbitux®) + mFOLFOX6 for BRAF V600E-Positive Metastatic Colorectal Cancer
Encorafenib (Braftovi®) + Cetuximab (Erbitux®) + mFOLFOX6 for BRAF V600E-Positive Metastatic Colorectal Cancer
About this PQI
The purpose of this PQI is to review clinical considerations related to the use of encorafenib combined with cetuximab and mFOLFOX6 (EC + mFOLFOX6) in patients with BRAF V600E-mutated metastatic colorectal cancer (mCRC).

How to Use a Positive Quality Intervention (PQI)
Essentially, it’s a tool to improve patient care by sharing best practices in oncology care. Consider this standardized, peer-review clinical guidance to oncology healthcare teams, enabling you and your team to consistently deliver high-quality care to your patients.
Find a PQIFind Similar Resources
All Resources
PQI
PQI
PQI
PQI
PQI: Zolbetuximab (Vyloy®) for Gastroesophageal Cancers
Author: Dr. Reetu Mukherji, MD
Last Updated: 07/22/2025
PQI: Advances in MRD Monitoring for Diffuse Large B-Cell Lymphoma (DLBCL)
Author: Tara Graff, DO, MS
Last Updated: 07/22/2025
PQI: Epcoritamab (Epkinly®) for Relapsed/Refractory Diffuse Large B-Cell Lymphoma and Follicular Lymphoma
Author: Syed Zia Khan, PharmD, BCSCP
Last Updated: 07/22/2025
PQI: Ibrutinib Dosing Optimization
Author: Nick Bouchard, PharmD | Danielle Maciorowski, PharmD
Last Updated: 07/22/2025
PQI in Action
PQI in Action
PQI in Action
PQI in Action
PQI in Action: Proactive Symptom Management in Myelofibrosis
Author: Cancer Specialists of North Florida
Last Updated: 07/22/2025
PQI in Action: Sonidegib (Odomzo®) Patient Management
Author: UCLA Medical Center | The Ohio State University Cancer Comprehensive Cancer Center (The James) | WVU Medicine
Last Updated: 07/22/2025
PQI in Action: Larotrectinib (Vitrakvi®) Overview
Author: Upstate Cancer Center/Upstate Golisano Children’s Hospital, NY | Wolfson Children’s Hospital, FL
Last Updated: 07/22/2025
PQI in Action: Tremelimumab-actl (Imjudo®) Patient Management
Author: Scripps Health, CA | UPMC, PA
Last Updated: 07/22/2025
Treatment Support Kit
Treatment Support Kit
Treatment Support Kit
Treatment Support Kit
Treatment Support Kit: Mirdametinib
Last Updated: 07/22/2025
Treatment Support Kit: Abemaciclib
Last Updated: 07/22/2025
Treatment Support Kit: Temozolomide
Last Updated: 07/22/2025
Treatment Support Kit: Tivozanib
Last Updated: 07/22/2025
PQI
PQI
PQI
PQI Podcast
PQI: Tucatinib (TUKYSA®) and trastuzumab in HER2-positive Metastatic Colorectal Cancer
Author: Matthew Arango, PharmD, BCOP
Last Updated: 07/22/2025
PQI: Trifluridine and Tipiracil (Lonsurf®) for Metastatic Colorectal Cancer
Author: Jennifer M. Hasiak O’Doherty, PharmD
Last Updated: 07/22/2025
PQI: Regorafenib (Stivarga®) in Metastatic Colorectal Cancer
Author: Neal Dave, PharmD | Natasha Khrystolubova, RPh, BPharm, BCOP
Last Updated: 07/22/2025
PQI Podcast S6 Ep 2: Molecular Testing & Targeted Treatment in Colorectal Cancer
Author: Ginger Blackmon, PharmD | Makenna Smack, PharmD, BCOP
Last Updated: 07/22/2025
PQI in Action
PQI in Action
Immunotherapy
Immunotherapy
PQI in Action: Proactive Symptom Management in Myelofibrosis
Author: Cancer Specialists of North Florida
Last Updated: 07/22/2025
PQI in Action: Sonidegib (Odomzo®) Patient Management
Author: UCLA Medical Center | The Ohio State University Cancer Comprehensive Cancer Center (The James) | WVU Medicine
Last Updated: 07/22/2025
Example SOPs and Documents: Transitioning Patients on Bispecific T-Cell Engagers Between Care Settings
Last Updated: 07/22/2025
Example SOPs and Documents: Bispecific T-cell Engager Billing Procedure
Last Updated: 07/22/2025